(PharmaNewsWire.Com, May 04, 2017 ) Publisher's new report, North America Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023, provides key procedures data on the North America Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve Gastrectomy Procedures and Other Methods.
The data in the report is derived from dynamic market forecast models. Publisher uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.
- North America Uterine Fibroid Embolization (UFE) Procedures volumes by segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve Gastrectomy Procedures and Other Methods. - Projections for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
